BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 2138167)

  • 21. [The effects of growth factors on gene expressions in human ovarian cancer cell line HO-8910].
    Chen X; Dai H; Wei L
    Zhonghua Zhong Liu Za Zhi; 1996 Sep; 18(5):351-5. PubMed ID: 9387273
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A benign serous ovarian cystadenoma studied by chromosome and quantitative DNA analysis.
    Wager J; Granberg I; Vass L; Auer G
    Acta Cytol; 1977; 21(6):774-6. PubMed ID: 274883
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A study of the methylation status of opioid binding protein/cell adhesion molecule-like gene in ovarian cancer using nested methylation-specific polymerase chain reaction detection.
    Zhou F; Cao X; Liu M; Wang Y; Tao G
    Clin Lab; 2011; 57(5-6):421-4. PubMed ID: 21755835
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simultaneous mucinous cystadenoma of ovary and mucinous cystadenocarcinoma of pancreas.
    Gagne LJ; Colacchio T; Longnecker DS
    Int J Pancreatol; 2000 Aug; 28(1):9-13. PubMed ID: 11185714
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ovarian carcinoma in identical twins.
    Tucker MH; Fryer JA; Saunders DM
    Aust N Z J Obstet Gynaecol; 1982 May; 22(2):113-5. PubMed ID: 6958248
    [No Abstract]   [Full Text] [Related]  

  • 26. [New technology of diagnosis of ovarian cancer].
    Terashima Y
    Gan No Rinsho; 1988 Aug; 34(10):1427-31. PubMed ID: 2845169
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Familial ovarian cancer.
    Lewis AC; Davison BC
    Lancet; 1969 Aug; 2(7614):235-7. PubMed ID: 4184107
    [No Abstract]   [Full Text] [Related]  

  • 28. Familial carcinoma of the ovary. Case report.
    Philipp EE
    Br J Obstet Gynaecol; 1979 Feb; 86(2):152-3. PubMed ID: 427055
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutation of K-ras protooncogene in human ovarian epithelial tumors of borderline malignancy.
    Mok SC; Bell DA; Knapp RC; Fishbaugh PM; Welch WR; Muto MG; Berkowitz RS; Tsao SW
    Cancer Res; 1993 Apr; 53(7):1489-92. PubMed ID: 8384077
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multivariate analyses of DNA index, p62c-myc, and clinicopathological status of patients with ovarian cancer.
    Curling M; Stenning S; Hudson CN; Watson JV
    J Clin Pathol; 1998 Jun; 51(6):455-61. PubMed ID: 9771445
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [ORIENTATIONAL CRITERIA IN RADIOTHERAPY OF PRIMARY TUMORS OF THE OVARY].
    BERGONZINI R; PASQUINELLI C; TORRICELLI A; VENDRAME L
    Minerva Radiol Fisioter Radiobiol; 1964 Jun; 16():264-77. PubMed ID: 14169292
    [No Abstract]   [Full Text] [Related]  

  • 32. Germline fumarate hydratase mutations in patients with ovarian mucinous cystadenoma.
    Ylisaukko-oja SK; Cybulski C; Lehtonen R; Kiuru M; Matyjasik J; Szymañska A; Szymañska-Pasternak J; Dyrskjot L; Butzow R; Orntoft TF; Launonen V; Lubiñski J; Aaltonen LA
    Eur J Hum Genet; 2006 Jul; 14(7):880-3. PubMed ID: 16639410
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cytogenetic findings in ovarian tumors (author's transl)].
    Knörr-Gärtner H; Schuhmann R; Uebele-Kallhardt B
    Verh Dtsch Ges Pathol; 1973; 57():203-7. PubMed ID: 4142176
    [No Abstract]   [Full Text] [Related]  

  • 34. [Chromosome abnormalities in an ovarian cancer].
    Berger R; Lacour J
    Pathol Biol (Paris); 1974 Sep; 22(7):603-6. PubMed ID: 4612464
    [No Abstract]   [Full Text] [Related]  

  • 35. [A cytogenetic study of ovarian cancer].
    Rodkina RA; Pogosiants EE; Chudina AP
    Akush Ginekol (Mosk); 1972 Jun; 48(6):46-53. PubMed ID: 5069558
    [No Abstract]   [Full Text] [Related]  

  • 36. [A quantitative study on nuclear DNA content and morphological parameters in ovarian cystadenocarcinoma].
    Liu C; Zhao Y; Sun X
    Zhonghua Fu Chan Ke Za Zhi; 1995 Dec; 30(12):738-40. PubMed ID: 8728920
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heterogeneous genetic alterations in ovarian mucinous tumors: application and usefulness of laser capture microdissection.
    Takeshima Y; Amatya VJ; Daimaru Y; Nakayori F; Nakano T; Inai K
    Hum Pathol; 2001 Nov; 32(11):1203-8. PubMed ID: 11727259
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical course of the disease in familial and non-familial forms of serous cystadenocarcinoma of the ovary].
    Akulenko LV; Nikogosian SO; Zhordaniia KI; Kozachenko VP
    Akush Ginekol (Mosk); 1991 Sep; (9):58-60. PubMed ID: 1746703
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In ovarian neoplasms, BRAF, but not KRAS, mutations are restricted to low-grade serous tumours.
    Sieben NL; Macropoulos P; Roemen GM; Kolkman-Uljee SM; Jan Fleuren G; Houmadi R; Diss T; Warren B; Al Adnani M; De Goeij AP; Krausz T; Flanagan AM
    J Pathol; 2004 Mar; 202(3):336-40. PubMed ID: 14991899
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Mucin histochemical and immunohistochemical studies of mucinous ovarian tumors].
    Shi ZL
    Zhonghua Bing Li Xue Za Zhi; 1989 Sep; 18(3):201-3. PubMed ID: 2636063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.